Market Overview

Global Cervical Cancer Diagnostics & Therapeutics Market Analysis, Growth, Trends & Forecasts 2018-2023, With an Expected CAGR of 6.3% - ResearchAndMarkets.com

Share:

The "Global
Cervical Cancer Diagnostics and Therapeutics Market - Segmented by
Diagnostic Test, By Therapeutics, End Users - Growth, Trends and
Forecasts (2018 - 2023)"
report has been added to ResearchAndMarkets.com's
offering.

The global cervical cancer diagnostics and therapeutics market is
expected to register a CAGR of 6.3% during the forecast period, 2018 to
2023.

The United States assists with coverage and reimbursement on Pap test
screening. Federal law has been passed by the Affordable Care Act (ACA)
to mandate the coverage of cervical cancer screening tests. It is also
supported by self-insured plans. Medicaid, the most popular government
insurance program covers screening for cervical cancers. Medicare,
another widely used insurance covers Pap test, pelvic exam, and a
clinical breast exam for cervical cancer screening every two years for
Medicare beneficiaries.

In middle-income and low-income developing countries, the existing
programs are failing to create major impact. This failure is mostly
attributed to the lack of or in many cases the absence of a healthcare
system that is capable of providing the diagnostic and treatment
services inseparable from screening. Many countries of Asia-Pacific and
Africa lack a proper healthcare infrastructure to provide the basic
medical amenities to people living in rural, and underdeveloped areas.

Asia-Pacific is expected to grow tremendously during the forecast
period, owing to factors, such as high prevalence of cervical cancer.
The high prevalence rate of cervical cancer among the population has
attributed to factors, such as less awareness regarding sexual hygiene
and precaution.

Companies Mentioned

  • Abbott.
  • Advaxis Inc.
  • Becton Dickinson And Company
  • Bristol-Meyrs Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Glaxosmithkline Plc
  • Qiagen N.V
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Quest Diagnostics Inc.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/qsl6v7/global_cervical?w=4

View Comments and Join the Discussion!